<!doctype html>
<html>
  <head>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=no">

    <title>07 Pain Response</title>

    <link rel="stylesheet" href="../../reveal/reset.css">
    <link rel="stylesheet" href="../../reveal/reveal.css">
    <link rel="stylesheet" href="../../reveal/theme.css" id="theme">
  </head>
  <body>
    <div class="reveal">
      <div class="slides">
        <section data-markdown>
          <textarea data-template>
            ### Pain Response
            #### (Chapter 32)
          </textarea>
        </section>
        <section>
          <section data-markdown>
            <textarea data-template>
              ## Question 1
              ---
              Describe the four stages of pain processing.
            </textarea>
          </section>
          <section data-markdown data-transition="slide">
            <textarea data-template>
              transduction
              <div class="fragment fade-up"><p>↓</p><p>transmission</p></div>
              <div class="fragment fade-up"><p>↓</p><p>perception</p></div>
              <div class="fragment fade-up"><p>↓</p><p>modulation</p></div>
            </textarea>
          </section>
          <section data-markdown data-transition="slide">
            <textarea data-template>
              **Transduction** is the **creation** of an electrical pain signal in the free nerve endings of a **nociceptor**.
              <p class="fragment fade-up">A noxious stimulus (heat, cold, mechanical pain) creates a <b>graded potiential</b> which, if intense enough, will trigger an <b>action potential</b>, leading to...</p>
            </textarea>
          </section>
          <section data-markdown data-transition="slide">
            <textarea data-template>
              **Transmission**, in which the action potential travels down the length of the nerve, entering the spinal cord and then traveling upward to the brain.
              <p class="fragment fade-up">Once it arrives in the brain...</p>
            </textarea>
          </section>
          <section data-markdown data-transition="slide">
            <textarea data-template>
              **Perception** occurs, in which the brain actually perceives or feels the sensation of pain.
              <p class="fragment fade-up">After the signal is received and processed in the brain...</p>
            </textarea>
          </section>
          <section data-markdown data-transition="slide">
            <textarea data-template>
              The final step, **modulation**, kicks in.
              <p class="fragment fade-up">The brain sends a signal <b>back down</b> the spine, causing the release of endogenous opioids which inhibit the pain signal at synapses <b>in the spinal cord</b>.</p>
            </textarea>
          </section>
        </section>
        <section>
          <section data-markdown>
            <textarea data-template>
              ## Question 2
              ---
              Why are these stages useful?
            </textarea>
          </section>
          <section data-markdown data-transition="slide">
            <textarea data-template>
              Understanding the four stages of pain processing is useful because they present us with the possible avenues of pain **treatment** and **prevention**.
            </textarea>
          </section>
          <section data-markdown data-transition="slide">
            <textarea data-template>
              You can:
              <ul>
                <li class="fragment fade-up">Block the signal from being created (at the source)
                <li class="fragment fade-up">Intercept or block the signal during transmission
                <li class="fragment fade-up">Alter the perception of the signal in the brain
              </ul>
              <p style="font-size:0.75em;" class="fragment fade-up">(We'll go into more depth on this with question 24.)</p>
            </textarea>
          </section>
        </section>
        <section>
          <section data-markdown>
            <textarea data-template>
              ## Question 3
              ---
              Describe the mechanism of action of non-steroidal anti-inflammatory drugs (NSAIDs) in relief from pain.
            </textarea>
          </section>
          <section data-markdown data-transition="slide">
            <textarea data-template>
              **Prostaglandins** are a type of chemical produced throuhout the body which play a vital role in the body's inflammatory response, producing pain, swelling, and vasodilation.
              <p class="fragment fade-up">They contribute to pain <b>transduction</b> by altering the membrane potential of nociceptors.</p>
            </textarea>
          </section>
          <section data-markdown data-transition="slide">
            <textarea data-template>
              Prostaglandins are produced by a pair of enzymes known as **cyclooxygenases** (COX-1 and COX-2,) which create them from the precursor **arachidonic acid**.
              <p class="fragment fade-up">NSAIDs block the action of one or both of these COX enzymes, reducing the body's ability to produce prostaglandins.</p>
              <p style="font-size:0.75em;" class="fragment fade-up">(Most NSAIDs block both, but a few, such as celecoxib (Celebrex) block only COX-2. You'll talk about this more in pharm.)</p>
            </textarea>
          </section>
        </section>
        <section>
          <section data-markdown>
            <textarea data-template>
              ## Question 4
              ---
              Describe the two types of pain fibers. What types of pain do they subserve?
            </textarea>
          </section>
          <section data-markdown data-transition="slide">
            <textarea data-template>
              Two types of nerve fibers involved in pain response:
              <p class="fragment fade-up"><b>Aδ (A-delta) fibers</b> are <b>thicker</b>, <b>myelinated</b> neurons, meaning <b>low resistance</b> and <b>super fast</b> transmission.</p>
              <p class="fragment fade-up"><b>C fibers</b> are <b>thinner</b> and <b>unmyelinated</b>, meaning the action potential travels <b>much more slowly</b>.</p>
            </textarea>
          </section>
          <section data-markdown data-transition="slide">
            <textarea data-template>
              Myelinated **Aδ fibers** enable **immediate response** to a stimulus by triggering quickly and getting the signal to the brain **as fast as possible**.
              <p class="fragment fade-up">They are usually associated with a sharp, stinging or burning sensation.</p>
            </textarea>
          </section>
          <section data-markdown data-transition="slide">
            <textarea data-template>
              Unmyelinated **C fibers**, which are much more numerous, provide a **low, ongoing response** to a persistent stimulus.
              <p class="fragment fade-up">They are usually associated with a dull, ongoing soreness or aching sensation.</p>
            </textarea>
          </section>
          <section data-markdown data-transition="slide">
            <textarea data-template>
              Example: When you get an injection, your Aδ fibers transmit the immediate "ouch." Your C fibers are the dull, sore sensation that lingers afterward.
            </textarea>
          </section>
        </section>
        <section>
          <section data-markdown>
            <textarea data-template>
              ## Question 5
              ---
              Where do the pain fibers enter the spinal cord? What is the major neurotransmitter released by pain fibers?
            </textarea>
          </section>
          <section data-markdown data-transition="slide">
            <textarea data-template>
              First, let's review some A&P...
            </textarea>
          </section>
          <section data-markdown data-transition="fade">
            <textarea data-template>
              <img src="question_5_fragment_0.svg" width="80%" />
              <p style="font-size:0.75em;">Remember that sensory (afferent) nerves enter through the <b>dorsal root</b>...</p>
            </textarea>
          </section>
          <section data-markdown data-transition="fade">
            <textarea data-template>
              <img src="question_5_fragment_1.svg" width="80%" />
              <p style="font-size:0.75em;">and motor (efferent) nerves exit through the <b>ventral root</b>.</p>
            </textarea>
          </section>
          <section data-markdown data-transition="fade">
            <textarea data-template>
              <img src="question_5_fragment_2.svg" width="80%" />
              <p style="font-size:0.75em;">Nociceptors are <b>pseudo-unipolar neurons</b> in the <b>dorsal root ganglia</b>.</p>
            </textarea>
          </section>
          <section data-markdown data-transition="slide">
            <textarea data-template>
              Pain signals originate from **free nerve endings** at the end of the nociceptor's dendrite, and travel along the dendrite towards the CNS.
              <p class="fragment fade-up">They then follow the axon through the <b>dorsal (posterior) root</b> and enter the gray matter of the spinal cord.</b>
            </textarea>
          </section>
          <section data-markdown data-transition="slide">
            <textarea data-template>
              The major **excitatory** neurotransmitter of sensory nerves (including nociceptors) is **glutamate**.
              <p class="fragment fade-up">Many other neurotransmitters are involved in pain tranmission, both excitatory (e.g. Substance P, CGRP) and inhibitory (e.g. γ-aminobutyric acid/GABA.)
            </textarea>
          </section>
          <section data-markdown data-transition="slide">
            <textarea data-template>
              One thing to know about glutamate:
              <p class="fragment fade-up">Repeated, long-term exposure of C fibers to glutamate can cause them to become <b>more sensitive</b>, leading to chronic pain <b>even after the stimulus is removed</b>.
              <p class="fragment fade-up">This condition is referred to as <b>central sensitization</b> or the "<b>wind-up phenomenon</b>."
            </textarea>
          </section>
        </section>
        <section>
          <section data-markdown>
            <textarea data-template>
              ## Question 6
              ---
              Which area of the spinal cord can enhance or inhibit pain?
            </textarea>
          </section>
          <section data-markdown data-transition="fade">
            <textarea data-template>
              <img src="question_6_fragment_0.svg" width="80%" />
              <p style="font-size:0.75em;">The gray matter of the spinal cord is divided into 10 areas called <b>laminae</b>.</p>
            </textarea>
          </section>
          <section data-markdown data-transition="fade">
            <textarea data-template>
              <img src="question_6_fragment_1.svg" width="80%" />
              <p style="font-size:0.75em;">Nociceptors synapse with second-order neurons and interneurons in laminae I, II, and V.</p>
            </textarea>
          </section>
          <section data-markdown data-transition="fade">
            <textarea data-template>
              <img src="question_6_fragment_2.svg" width="80%" />
              <p style="font-size:0.75em;">Pain modulation primarily occurs in lamina II, the <b>substantia gelatinosa</b>.</p>
            </textarea>
          </section>
        </section>
        <section>
          <section data-markdown>
            <textarea data-template>
              ## Question 7
              ---
              Describe the difference between the neospinothamalic and paleospinothalamic tracts.
            </textarea>
          </section>
          <section data-markdown data-transition="fade">
            <textarea data-template>
              <img src="question_7_fragment_0.svg" width="80%" />
              <p style="font-size:0.75em;">Both <b>spinothalamic tracts</b> are found in the <b>anterolateral white column</b>.</p>
            </textarea>
          </section>
          <section data-markdown data-transition="slide">
            <textarea data-template>
              The **neospinothamalic** division carries signals from **Aδ** (fast) fibers towards the cerebral cortex, synapsing again in the thalamus.
              <p class="fragment fade-up">The <b>paleospinothalamic</b> division carries signals from <b>C</b> (slow) fibers to various destinations in the midbrain.</p>
            </textarea>
          </section>
        </section>
        <section>
          <section data-markdown>
            <textarea data-template>
              ## Question 8
              ---
              Which lamina of the spinal cord dorsal horn gray matter is involved in referred pain?
            </textarea>
          </section>
          <section data-markdown data-transition="fade">
            <textarea data-template>
              <img src="question_8_fragment_0.svg" width="80%" />
              <p style="font-size:0.75em;">Referred pain originates in lamina V. Why does referred pain occur?</p>
            </textarea>
          </section>
          <section data-markdown data-transition="slide">
            <textarea data-template>
              Neurons synapsing in lamina V have "**wide dynamic range**," meaning they transmit a wide range of visceral and somatic sensory signals.
              <p class="fragment fade-up">This can lead to neurons getting cross-wired and visceral pain being interpreted as somatic pain.</p>
            </textarea>
          </section>
        </section>
        <section>
          <section data-markdown>
            <textarea data-template>
              ## Question 9
              ---
              At what level of the brain is pain interpreted?
            </textarea>
          </section>
          <section data-markdown data-transition="slide">
            <textarea data-template>
              The sensation and quality of pain are interpreted in the **primary sensory cortex**. Remember that this is the final destination of the **neospinothalamic tract**.
              <p class="fragment fade-up">In contrast, the <b>midbrain</b> controls only the conscious awareness of pain, not interpretation.</p>
            </textarea>
          </section>
        </section>
        <section>
          <section data-markdown>
            <textarea data-template>
              ## Question 10
              ---
              Dermatomal maps help which function in pain?
            </textarea>
          </section>
          <section data-markdown data-transition="slide">
            <textarea data-template>
              **Dermatomal maps** provide a layout of which areas of the body are innervated by neurons from each level of the spinal column.
              <p class="fragment fade-up">This is useful for determining the source of <b>neuropathic</b> pain.</p>
              <p class="fragment fade-up">If you determine where it <b>feels</b> like the pain is coming from, you can determine which nerves are involved.</p>
            </textarea>
          </section>
        </section>
        <section>
          <section data-markdown>
            <textarea data-template>
              ## Question 11
              ---
              Distinguish between pain tolerance and pain expression.
            </textarea>
          </section>
          <section data-markdown data-transition="slide">
            <textarea data-template>
              **pain tolerance** - how much pain you can **internally** handle
              <p style="font-size:0.75em;" class="fragment fade-up">(How much pain does it take before it becomes unbearable and you seek relief?)</p>
            </textarea>
          </section>
          <section data-markdown data-transition="slide">
            <textarea data-template>
              **pain expression** - how do you externally display or communicate your pain to others?</p>
              <p class="fragment fade-up"><b>Both</b> of these vary widely from person to person, and pain expression also has a strong <b>cultural aspect</b>.</p>
            </textarea>
          </section>
        </section>
        <section>
          <section data-markdown>
            <textarea data-template>
              ## Question 12
              ---
              Describe presynaptic inhibition of pain. Which neurotransmitter is involved?
            </textarea>
          </section>
          <section data-markdown data-transition="slide">
            <textarea data-template>
              **Presynaptic inhibition** occurs when a **first-order neuron** is prevented from transmitting its signals to a second-order neuron or interneuron.
              <p class="fragment fade-up"><b>Opioids</b> such as β-endorphin and enkephalins play a role, as does the neurotransmitter γ-aminobutyric acid (GABA.)</p>
            </textarea>
          </section>
        </section>
        <section>
          <section data-markdown>
            <textarea data-template>
              ## Question 13
              ---
              Describe the gate control theory of pain relief.
            </textarea>
          </section>
          <section data-markdown data-transition="slide">
            <textarea data-template>
              Thick **Aβ fibers** linked to **touch** receptors can **take priority** over Aδ/C pain signals when stimulated.
              <p class="fragment fade-up"><b>Gate control theory</b> states that pain can be reduced by providing an additional, non-noxious stimulus to trigger Aβ fibers and cut off pain transmission.</p>
            </textarea>
          </section>
        </section>
        <section>
          <section data-markdown>
            <textarea data-template>
              ## Question 14
              ---
              What are the names of the endogenous and exogenous opioids?
            </textarea>
          </section>
          <section data-markdown data-transition="slide">
            <textarea data-template>
              First, what *are* endogenous and exogenous opioids?
              <p class="fragment fade-up"><b>endogenous opioids</b> – opioids produced <b>internally</b> by the body</p>
              <p class="fragment fade-up"><b>exogenous opioids</b> – <b>external</b> opioids introduced to the body, e.g. as drug therapy</p>
            </textarea>
          </section>
          <section data-markdown data-transition="slide">
            <textarea data-template>
              Examples:
              <p class="fragment fade-up"><b>endogenous opioids</b> – endorphins, enkephalins</p>
              <p style="font-size:0.75em;" class="fragment fade-up">(endorphins = "endogenous morphine")</p>
              <p class="fragment fade-up"><b>exogenous opioids</b> – morphine, codeine, hydrocodone, methadone, etc.</p>
            </textarea>
          </section>
        </section>
        <section>
          <section data-markdown>
            <textarea data-template>
              ## Question 15
              ---
              Which of the opioid receptors provide analgesia?
            </textarea>
          </section>
          <section data-markdown data-transition="slide">
            <textarea data-template>
              There are four types of opioid receptors in the CNS:
              <ul>
                <li class="fragment fade-up" data-fragment-index="0">μ (mu)<span class="fragment fade-up" data-fragment-index="4"> ← ⭐</span></li>
                <li class="fragment fade-up" data-fragment-index="1">κ (kappa)<span class="fragment fade-up" data-fragment-index="4"> ← ⭐</span></li>
                <li class="fragment fade-up" data-fragment-index="2">σ (sigma)</li>
                <li class="fragment fade-up" data-fragment-index="3">δ (delta)</li>
              </li>
              <p class="fragment fade-up" data-fragment-index="4"><b>μ (mu)</b> and <b>κ (kappa)</b> are the two involved in pain modulation.</p>
            </textarea>
          </section>
        </section>
        <section>
          <section data-markdown>
            <textarea data-template>
              ## Question 16
              ---
              Pain is classified according to three criteria. What are they?
            </textarea>
          </section>
          <section data-markdown data-transition="slide">
            <textarea data-template>
              **duration** – is it **acute** or **chronic**?
              <p class="fragment fade-up"><b>source</b> – neuropathic, ischemic, somatic, visceral, etc.</p>
              <p class="fragment fade-up"><b>location</b> – where is the pain being experienced?</p>
            </textarea>
          </section>
        </section>
        <section>
          <section data-markdown>
            <textarea data-template>
              ## Question 17
              ---
              What is fibromyalgia? Describe it.
            </textarea>
          </section>
          <section data-markdown data-transition="slide">
            <textarea data-template>
              A chronic disease characterized by **widespread musculoskeletal pain** and **extreme tenderness** at specific areas of the body.
              <p class="fragment fade-up"><b>Allodynia</b>, which we'll talk about in a second, is a typical symptom of fibromyalgia.</p>
            </textarea>
          </section>
        </section>
        <section>
          <section data-markdown>
            <textarea data-template>
              ## Question 18
              ---
              How does cancer cause pain?
            </textarea>
          </section>
          <section data-markdown data-transition="slide">
            <textarea data-template>
              There are many mechanisms, any of which can be considered "cancer-related" pain. They can include:
              <ul>
                <li class="fragment fade-up">Infiltration of organs by cancerous growth</li>
                <li class="fragment fade-up">Pressure on nerves from a tumor (neuropathic)</li>
                <li class="fragment fade-up">Pain secondary to cancer treatment (iatrogenic)</li>
              </ul>
            </textarea>
          </section>
        </section>
        <section>
          <section data-markdown>
            <textarea data-template>
              ## Question 19
              ---
              How is neuropathic pain different from tissue injury pain?
            </textarea>
          </section>
          <section data-markdown data-transition="slide">
            <textarea data-template>
              Most (somatic/visceral) pain signals **damage to tissues**.
              <p class="fragment fade-up">In <b>neuropathic pain</b>, the <b>nerve itself</b> is the source of the pain, rather than responding to an external stimulus.</p>
              <p class="fragment fade-up">Neuropathic pain often has a shooting/burning quality and radiates along the path of the nerve.</p>
            </textarea>
          </section>
          <section data-markdown data-transition="slide">
            <textarea data-template>
              Examples include:
              <p class="fragment fade-up"><b>sciatica</b> – neuropathy due to impingement of sciatic nerve</p>
              <p class="fragment fade-up"><b>trigeminal neuralgia</b> – facial neuropathy due to demyelination of trigeminal nerve</p>
              <p class="fragment fade-up"><b>diabetic neuropathy</b> – neuropathy due to poor circulation to peripheral nerves</p>
            </textarea>
          </section>
        </section>
        <section>
          <section data-markdown>
            <textarea data-template>
              ## Question 20
              ---
              Define allodynia and hyperalgesia.
            </textarea>
          </section>
          <section data-markdown data-transition="slide" data-background-color="rgb(23,66,153)">
            <textarea data-template>
              <p><b><i>állos</i></b> (other)</p>
              <p class="fragment fade-in"><b><i>odúnē</i></b> (pain)</p>
            </textarea>
          </section>
          <section data-markdown data-transition="slide" data-background-color="rgb(23,66,153)">
            <textarea data-template>
              **allodynia**
              ---
              "a **painful** response to a typically **non-painful** stimulus"
            </textarea>
          </section>
          <section data-markdown data-transition="slide" data-background-color="rgb(153,23,45)">
            <textarea data-template>
              <p><b><i>hupér</i></b> (over)</p>
              <p class="fragment fade-in"><b><i>algéō</i></b> (to feel pain)</p>
            </textarea>
          </section>
          <section data-markdown data-transition="slide" data-background-color="rgb(153,23,45)">
            <textarea data-template>
              **hyperalgesia**
              ---
              "an **exaggerated** or **prolonged** response to a painful stimulus"
            </textarea>
          </section>
          <section data-markdown data-transition="slide">
            <textarea data-template>
              Remember one common source of allodynia: **fibromyalgia**.
            </textarea>
          </section>
        </section>
        <section>
          <section data-markdown>
            <textarea data-template>
              ## Question 21
              ---
              Describe diabetic neuropathy. How are the senses changed?
            </textarea>
          </section>
          <section data-markdown data-transition="slide">
            <textarea data-template>
              Chronically elevated blood glucose causes damage to peripheral blood vessels, resulting in **ischemia** of peripheral nerves (usually in legs and feet.)
              <p class="fragment fade-up">This can result in both motor changes such as weakness, and sensory changes (numbness, tingling, and pain.)</p>
            </textarea>
          </section>
        </section>
        <section>
          <section data-markdown>
            <textarea data-template>
              ## Question 22
              ---
              Describe referred pain, post-herpetic neuralgia, and ischemic pain.
            </textarea>
          </section>
          <section data-markdown data-transition="slide">
            <textarea data-template>
              **referred pain** – "cross-wiring" between visceral and somatic pain neurons results in visceral pain being interpreted as somatic
              <p style="font-size:0.75em;" class="fragment fade-up">(Remember the role of lamina V in this process.)</p>
            </textarea>
          </section>
          <section data-markdown data-transition="slide">
            <textarea data-template>
              **post-herpetic neuralgia** – a common sequela of **shingles** in which chronic pain persists long after the initial infection has cleared
            </textarea>
          </section>
          <section data-markdown data-transition="slide">
            <textarea data-template>
              **ischemic pain** – acute pain due to insufficient blood flow (and thus insufficient oxygen) to tissues
              <p style="font-size:0.75em;" class="fragment fade-up">(An associated term is <b>claudication</b>, ischemic pain—often in the legs—which goes away with rest.)</p>
            </textarea>
          </section>
        </section>
        <section>
          <section data-markdown>
            <textarea data-template>
              ## Question 23
              ---
              What are some differences in pain therapy in the young and the elderly?
            </textarea>
          </section>
          <section data-markdown data-transition="slide">
            <textarea data-template>
              Pain in the very young can be harder to diagnose and treatment is sometimes lacking.
              <p class="fragment fade-up">Insufficient treatment can lead to long-term changes in the CNS.</p>
              <p class="fragment fade-up">Elderly patients can also experience pain that goes inadequately treated.</p>
            </textarea>
          </section>
        </section>
        <section>
          <section data-markdown>
            <textarea data-template>
              ## Question 24
              ---
              Describe the three points of pain management. Give examples.
            </textarea>
          </section>
          <section data-markdown data-transition="slide">
            <textarea data-template>
              1. **blocking transduction or transmission**
              <ul>
                <li>NSAIDs</li>
                <li>local infiltration/nerve block</li>
              </ul>
            </textarea>
          </section>
          <section data-markdown data-transition="slide">
            <textarea data-template>
              2. **blocking/modulating pain at the spinal cord**
              <ul>
                <li>Transcutaneous Electrical Nerve Stimulation (TENS)</li>
                <li>Epidural anesthesia</li>
              </ul>
            </textarea>
          </section>
          <section data-markdown data-transition="slide">
            <textarea data-template>
              3. **altering perception of pain in the brain**
              <ul>
                <li>Opioid analgesics</li>
                <li>Non-pharmacologic techniques (breathing, relaxation techniques, etc.)</li>
              </ul>
            </textarea>
          </section>
        </section>
      </div>
    </div>

    <script src="../../reveal/reveal.js"></script>
    <script src="../../reveal/markdown.js"></script>
    <script>
      Reveal.initialize({
        hash: true,
        plugins: [ RevealMarkdown ],
        transition: 'convex',
        backgroundTransition: 'slide',
        pdfSeparateFragments: false
      });
    </script>
  </body>
</html>
